Typically used for early identification of an active infection in symptomatic patient at the point of care. Reliable results without cross-reactivity to seasonal coronaviruses.

Direct nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset.

Your benefits:

• Cost-effective, high performing test designed for decentralised testing.
• Simple test procedure using a direct nasal swab.
• Enable intuitive sample processing with prefilled, utilized tubes.
• 18 month storage at RT.
• Rapid results within 15 minutes without instrument required.

Mandatory text:
The buyer is aware that the antigen rapid tests sold may only be used by qualified medical personnel (physicians, or comparable/ §3 MPAV in conjunction with §3 No. 17 MPG), in particular, but not exclusively, with regard to the reliability of the results of the rapid tests. By placing an order, the buyer confirms that he ensures that the rapid tests sold are only carried out by sufficiently qualified persons.